Current research opportunities
Research advertised below is provided as a service to the diabetes research community. This research is not specifically endorsed by Diabetes Australia.
All studies and surveys that are promoted on the Diabetes Australia website and social media channels are reviewed by the Medical Education and Scientific Council (MESC). If you would like to promote a survey or ask for participants, email email@example.com
Type1Screen is a new Australian and New Zealand initiative offering free type 1 diabetes risk screening.
The aim of Type1Screen is to identify people at risk of developing type 1 diabetes (i.e. the presence of islet autoantibodies in the blood).
To be eligible for Type1Screen, individuals must be aged between 2 – 30 years and have a family history of type 1 diabetes.
Participation involves signing a consent form and having a blood test at a local pathology collection centre. The blood is sent to a lab in Melbourne and results are sent back within 8 weeks. Further information about Type1Screen is available at the Type1Screen website.
Those who are found to be antibody-positive will be supported through a national network of diabetes centres and offered further testing to determine their risk of developing diabetes. They will also be offered the opportunity to enter any available prevention studies.
To take part or ask for more information send an email to Type1Screen@mh.org.au
Type 2 Diabetes Heart Rate Variability Study
- Do you have type 2 diabetes?
- Live near Sydney?
- Aged between 18 and 69?
Researchers at the University of Technology Sydney would like you to wear a small heart-rate monitor for 90-minutes while you enjoy a meal of your choice near the university.
Participants will be offered a small reimbursement for their time.
We are interested in how certain heart rhythms may be able to predict blood glucose levels, which may be useful in the development of a non-invasive indicator of blood glucose.
Want to get involved or just find out more? Contact Luke Jarman on (Ph) 0410724067 or (Email) Luke.Jarman@uts.edu.au
This study has been approved by the University of Technology, Sydney Human Research Ethics Committee (HREC: 2014000110).
If you have any complaints or reservations about any aspect of your participation in this research which you cannot resolve with the researcher, you may contact the Ethics Committee through the Research Ethics Officer (ph: 02 9514 9615, Research.Ethics@uts.edu.au) and quote the UTS HREC reference number.
Any complaint you make will be treated in confidence and investigated fully and you will be informed of the outcome.
Queensland University of Technology online research survey
Participate in an online research study exploring how adults with chronic neuropathic pain perceive different visual words.
Queensland University of Technology (QUT) invites you to participate in an online study.
This project aims to investigate how adults with chronic neuropathic pain perceive different visual words.
Participation involves completing a 15-minute online survey, followed by 30-minutes of online rating/judgement tasks. You will be offered a $10 WISH e-gift card upon completion.
To be eligible, you must meet the following criteria:
- Be aged 18 years or older.
- Be a native English speaker. That is, English is the first language you learned.
- Have access to a desktop or laptop computer connected to reliable internet.
- Experience chronic neuropathic pain. That is, pain lasting longer than 3 months and caused by a lesion or disease of the nervous system (e.g., diabetic neuropathy, cancer-related neuropathic pain, post-herpetic neuralgia caused by shingles).
Find out more and enter the survey here.
For any questions, please email firstname.lastname@example.org
Please note that this study has been approved by the QUT Human Research Ethics Committee (approval number 1800001005).
Reducing the Risk of Heart Failure
Study Volunteers Needed
If you are 65+ years of age, and have one of the following conditions, you may qualify for an important study to reduce the risk of Heart Failure:
- Type 2 Diabetes
- High Blood Pressure (or on treatment)
This is a 2 year study with follow up at 6 months, 12 months and 24 months.
Participants will receive 2 x echocardiogram (painless ultrasound of the heart) and 2 x ECG (painless measurement of heart activity using electrodes placed on the skin) over 2 years.
Medication may be prescribed if signs of early stage heart failure are detected from the baseline echo.
If you are interested and would like further information, please call Jo Harris o (03) 8532 1511 or email Baker.VICELF@baker.edu.au
Social Support, Diabetes Self-Management & Mood
We are conducting a study exploring social support, diabetes self-management (self-care) and mood, and would like your help!
- have type 2 diabetes,
- are aged 18 or older; and
- have not been diagnosed with a psychological condition that currently affects mood or cognitive functioning (for example a major depressive disorder or cognitive impairment)
and are interested in participating, please click on this survey link for more information and/or participate in an online, anonymous survey.
The survey will take approximately 30 minutes or less and will ask for information about your background (for example age and gender, how you manage type 2 diabetes, any social support you receive and your mood.
If you would like further information via email, please contact Ms Sally Tavares (Student Researcher) email@example.com
This study has received approval from the Federation University Human Research Ethics Committee
What causes type 1 diabetes?
The ENDIA (Environmental Determinants of Islet Autoimmunity) Study is looking into the causes of type 1 diabetes.
We all have our theories, but we really don’t know what triggers, or what protects, some children from developing type 1 diabetes.
- Pregnant women with type 1 diabetes, or
- Men with type 1 diabetes whose partner is pregnant, or
- Children with type 1 diabetes whose mother is pregnant, or
- Babies up to 6 months of age whose first degree relative (mum, dad, brother or sister) have type 1 diabetes.
ENDIA is a national observational study. There are no interventions and there is no impact on normal health care. There is a regional program, so families can participate from anywhere in Australia.
Participation involves regular follow-up including questionnaires, basic measurements such as baby’s height and weight, and samples such as saliva and skin swabs to look at all the different environmental factors baby has experienced as he or she grows.
More information can be found on the website: www.endia.org.au or by contacting the team directly at firstname.lastname@example.org.
Do you have Type 2 diabetes and foot nerve damage?
People with Type 2 Diabetes may develop foot nerve damage (peripheral neuropathy), as a complication. Symptoms might include: numbness of the feet; coldness in the legs; tingling or pins and needles in the feet; burning pain in the feet and legs. Peripheral neuropathy can affect balance and walking, and increase the risk of falling. Researchers at The University of Queensland are seeking participants for a trial of different shoe insoles which may improve balance, walking and foot sensation in adults with Type 2 diabetes and peripheral neuropathy.
I’m interested, what would be involved?
You would be given a pair of shoe insoles to wear for 4 weeks. Across 2 sessions we will measure the feeling in your feet, standing balance, and walking ability whilst barefoot, wearing shoes, and 2 different insoles (textured and smooth). You will be required to wear a small wireless activity monitor for 2 weeks, and complete 3 short surveys relating to your general health, diabetes, foot health, falls, and experience wearing the insoles.
Am I eligible to take part?
To be eligible to participate in this trial you MUST: - be aged 18 years or older - have Type 2 diabetes and peripheral neuropathy - live in South East Queensland - be able to walk over 20 metres with/without an aid (e.g. walking stick) - be willing to wear shoe insoles for 4 weeks
There are some medical conditions that would make you ineligible to take part. Please contact the lead researcher, Dr Anna Hatton, to find out more (see below).
What will I receive for taking part?
Participants will be remunerated for their transport to and from The University of Queensland (St Lucia campus) for assessments, by way of return taxi fares (within the Brisbane region) or day car parking.
To register your interest to take part, please follow the survey link below: https://www.surveymonkey.com/r/GKCMFJJ
I would like to know more: Please contact Dr Anna Hatton on: (Tel) 07 3365 4590 or (Email) email@example.com
Type 1 Diabetes TrialNet
Find out if your family is at risk and help your community
What is TrialNet?
TrialNet is a global program to screen relatives of people with type 1 diabetes. This trial can help you and your family find out your risk of developing type 1 diabetes, allowing for early treatment. Your participation will also help determine how to prevent type 1 diabetes.
Get peace of mind and help prevent diabetes.
TrialNet is dedicated to the study, prevention, and early treatment of type 1 diabetes. It works with more than 200 screening sites throughout Australia, the United States, Canada, Finland, United Kingdom, Italy and New Zealand. TrialNet is supported by the National Institutes of Health, which is part of the United States Federal Government. It is also supported by Diabetes Australia, JDRF Australia and major diabetes organisations in other countries.
Find out more: www.diabetestrialnet.org
Clinical Trials Connect
Clinical Trials Connect (CTC) was established in 2008. CTC is an online participant recruitment website designed to help match members of the Australian community to research opportunities Australia wide, and deliver recruitment solutions to researchers.
People can register their interest to participate in trials on the website either as a healthy volunteer or as a patient with an existing medical condition.